2011•Zhongguo zhongyiyao xinxi zazhiRequires access

Anti-tumor Effect of Qishengheji and Its Influence on Myelosuppression Caused by Chemotherapy in S180 Tumor-bearing Mice

Shen Xiao-heng

Open publisher page 0 citations

Abstract

Objective To observe the effect of Qishengheji on myelosuppression caused by chemotherapy in S180 tumor-bearing mice.Methods Sixty mice were randomly divided into six groups,including normal control group,S180 control group,Cyclophosphamide(CTX) group,and high,medium and low dose of Qishengheji group.All mice except normal control group were vaccinated with S180 cells in armit of the right forearm,and administrated with corresponding drugs for 10 days.The administration groups were injected CTX intraperitoneally at 4th day after vaccination for 3 days.The normal control group and S180 control group were given NS.The peripheral blood routine,the inhibiting tumor rate and the weight of tumor were examined.Result Qishengheji improved the peripheral white blood cell(WBC) of S180 tumor-bearing mice with chemotherapy,the difference was significant compared with CTX group(P0.01).PLT was lower in CTX group and Qishengheji groups than that in S180 control group(P0.01).The tumor grew rapidly in S180 control group,and the weight of tumor in each dose of Qishengheji group and CTX group was lower than S180 control group(P0.01).There was significant difference between CTX group and medium dose of Qishegheji group(P0.01).CTX inhibited the growth of tumor,and the tumor inhibition rate was 49.69%.The tumor inhibition rate of high,medium and low dose of Qishengheji group combined with CTX was 60.55%,72.11% and 64.48%,respectively.Conclusion Qishengheji can enhance the efficacy and reduce the side effect of chemotherapy in S180 tumor-bearing mice.

About this research paper

What this paper is about

Objective To observe the effect of Qishengheji on myelosuppression caused by chemotherapy in S180 tumor-bearing mice.Methods Sixty mice were randomly divided into six groups,including normal control group,S180 control group,Cyclophosphamide(CTX) group,and high,medium and low dose of Qishengheji group.All mice except normal control group were vaccinated with S180 cells in armit of the right forearm,and administrated with corresponding drugs for 10 days.The administration groups were injected CTX intraperitoneally at 4th day after vaccination for 3 days.The normal control group and S180 control group were given NS.The peripheral blood routine,the inhibiting tumor rate and the weight of tumor were examined.Result Qishengheji improved the peripheral white blood cell(WBC) of S180 tumor-bearing mice with chemotherapy,the difference was significant compared with CTX group(P0.01).PLT was lower in CTX group and Qishengheji groups than that in S180 control group(P0.01).The tumor grew rapidly in S180 control group,and the weight of tumor in each dose of Qishengheji group and CTX group was lower than S180 control group(P0.01).There was significant difference between CTX group and medium dose of Qishegheji group(P0.01).CTX inhibited the growth of tumor,and the tumor inhibition rate was 49.69%.The tumor inhibition rate of high,medium and low dose of Qishengheji group combined with CTX was 60.55%,72.11% and 64.48%,respectively.Conclusion Qishengheji can enhance the efficacy and reduce the side effect of chemotherapy in S180 tumor-bearing mice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of Qishengheji on myelosuppression caused by chemotherapy in S180 tumor-bearing mice.Methods Sixty mice were randomly divided into six groups,including normal control group,S180 control group,Cyclophosphamide(CTX) group,and high,medium and low dose of Qishengheji group.All mice except normal control group were vaccinated with S180 cells in armit of the right forearm,and administrated with corresponding drugs for 10 days.The administration groups were injected CTX intraperitoneally at 4th day after vaccination for 3 days.The normal control group and S180 control group were given NS.The peripheral blood routine,the inhibiting tumor rate and the weight of tumor were examined.Result Qishengheji improved the peripheral white blood cell(WBC) of S180 tumor-bearing mice with chemotherapy,the difference was significant compared with CTX group(P0.01).PLT was lower in CTX group and Qishengheji groups than that in S180 control group(P0.01).The tumor grew rapidly in S180 control group,and the weight of tumor in each dose of Qishengheji group and CTX group was lower than S180 control group(P0.01).There was significant difference between CTX group and medium dose of Qishegheji group(P0.01).CTX inhibited the growth of tumor,and the tumor inhibition rate was 49.69%.The tumor inhibition rate of high,medium and low dose of Qishengheji group combined with CTX was 60.55%,72.11% and 64.48%,respectively.Conclusion Qishengheji can enhance the efficacy and reduce the side effect of chemotherapy in S180 tumor-bearing mice.

Key concepts: Cyclophosphamide, Chemotherapy, Medicine, Peripheral blood, Internal medicine, Pharmacology, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Anti-tumor Effect of Qishengheji and Its Influence on Myelosuppression Caused by Chemotherapy in S180 Tumor-bearing Mice — Research Paper | ScholarLens